New theory on why more women than men develop autoimmune diseases

June 5, 2018, University of Gothenburg

New findings are now being presented on possible mechanisms behind gender differences in the occurrence of rheumatism and other autoimmune diseases. The study, published in Nature Communications, can be of significance for the future treatment of diseases.

"It's very important to understand what causes these diseases to be so much more common among women," says Åsa Tivesten, professor of medicine at Sahlgrenska Academy, Sweden, a chief physician and one of the authors of the study. "In this way, we can eventually provide better treatment for the diseases."

In , the immune system creates antibodies that attack the body's own tissue. Almost all autoimmune diseases affect women more often than men. The gender difference is especially great in the case of lupus, a serious also known as or SLE. Nine out of ten of those afflicted are women.

It has been known that there is a link between the male sex hormone testosterone and protection against autoimmune diseases. Men are generally more protected than , who only have one tenth as much testosterone.

New possible mechanisms

Testosterone reduces the number of B cells, a type of lymphocyte that releases harmful antibodies. The researchers behind the study were trying to understand what the connection between testosterone and the production of B cells in the spleen actually looks like, mechanisms that have so far been unknown.

After numerous experiments on mice and studies of blood samples from 128 men, the researchers were able to conclude that the critical connection is the protein BAFF, which makes the B cells more viable.

"We have concluded that testosterone suppresses BAFF. If you eliminate testosterone, you get more BAFF and thereby more B in the spleen because they survive to a greater extent. Recognition of the link between and BAFF is completely new. No one has reported this in the past," says Åsa Tivesten.

Better use of medicines

The results correlate well with a previous study showing that genetic variations in BAFF can be linked to the risk of diseases such as lupus. That disease is treated with BAFF inhibitors, a medicine that has not, however, really lived up to expectations.

"That's why this information about how the body regulates the levels of BAFF is extremely important, so that we can continue to put the pieces together and try to understand which patients should have BAFF inhibitors and which should not. Accordingly, our study serves as a basis for further research on how the medicine can be used in a better way."

Explore further: Breakthrough opens door to safer lupus drugs

More information: Anna S. Wilhelmson et al. Testosterone is an endogenous regulator of BAFF and splenic B cell number, Nature Communications (2018). DOI: 10.1038/s41467-018-04408-0

Related Stories

Breakthrough opens door to safer lupus drugs

May 14, 2015
A ground-breaking discovery by Monash University researchers could revolutionise treatments given to lupus sufferers, saving thousands of people each year from serious illness or death caused by secondary infections.

First lupus breakthrough in 50 years

April 28, 2011
(Medical Xpress) -- A Monash researcher has played a crucial role in the first major lupus treatment breakthrough for over 50 years.

Genetic variant tied to MS and systemic lupus identified

April 27, 2017
(HealthDay)—A genetic variant that is associated with both multiple sclerosis and systemic lupus erythematosus (SLE) has been identified, according to a study published online April 26 in the New England Journal of Medicine.

New findings link estrogen and T cell immune response to autoimmune inflammation

June 1, 2018
Women are more prone to the development of autoimmune diseases. The female hormone estrogen is likely to affect the immune system. A team of scientists from Turku Center for Biotechnology and University of Georgia reported ...

Researchers use blood serum markers to develop lupus risk index

May 31, 2018
Researchers at the Feinstein Institute for Medical Research, USA have developed an index that identifies the risk for lupus based on the presence and amount of Immunoglobin G (IgG) and Immunoglobin M (IgM) antibodies and ...

New mutation linked to non-Hodgkin's lymphoma

November 1, 2010
Some patients with non-Hodgkin lymphoma (NHL) -- a cancer of B cells -- harbor a particular mutation in the gene encoding the receptor for B cell activating factor (BAFF), according to a paper published online on November ...

Recommended for you

Researchers uncover immune cell dysfunction linked to photosensitivity

August 16, 2018
Researchers at Hospital for Special Surgery (HSS) have discovered that a type of immune cell known as Langerhans appears to play an important role in photosensitivity, an immune system reaction to sunlight that can trigger ...

Chemicals found in vegetables prevent colon cancer in mice

August 14, 2018
Chemicals produced by vegetables such as kale, cabbage and broccoli could help to maintain a healthy gut and prevent colon cancer, a new study from the Francis Crick Institute shows.

Researchers artificially generate immune cells integral to creating cancer vaccines

August 14, 2018
For the first time, Mount Sinai researchers have identified a way to make large numbers of immune cells that can help prevent cancer reoccurrence, according to a study published in August in Cell Reports.

Doctors may be able to enlist a mysterious enzyme to stop internal bleeding

August 14, 2018
Blood platelets are like the sand bags of the body. Got a cut? Platelets pile in to clog the hole and stop the bleeding.

Team finds missing immune cells that could fight lethal brain tumors

August 13, 2018
Glioblastoma brain tumors can have an unusual effect on the body's immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body's defenses.

The medicine of the future against infection and inflammation?

August 13, 2018
Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body's own peptides act to reduce infection and inflammation by deactivating the toxic substances ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.